Archives
-
Coumestrol in Cell Assays: A Practical Design Guide
2026-09-25
This scenario-driven guide shows how to plan viability, proliferation, and cytotoxicity experiments with Coumestrol (SKU C5832), while distinguishing receptor pharmacology from the higher-concentration effects reported in rheumatoid arthritis fibroblast-like synoviocytes. It covers assay interpretation, solution handling, vendor selection, and evidence-based limits.
-
GABAB Antagonism in Astrocyte–Neuron Research
2026-09-25
A translational framework for using CGP 55845 hydrochloride to test GABAB-dependent contributions to synaptic signaling—while keeping astrocytic GAT-3 mechanisms and their evidential limits distinct.
-
EGTA and Calcium Causality in Neural Assays
2026-09-24
EGTA (egtazic acid) helps researchers test whether calcium availability is necessary for a cellular response—not which channel produced it. This article connects selective chelation to the interpretation of neural electrophysiology, injury models, and practical assay design.
-
Wortmannin: From PI3K Mechanism to Translation
2026-09-24
A mechanistic and translational guide to using Wortmannin to interrogate PI3K signaling, cancer biology, and viral entry—while accounting for its irreversible action, kinase cross-reactivity, and experimental limits.
-
DiI (DiIC18(3)) Membrane Probe Workflow
2026-09-23
DiI (DiIC18(3)) labels lipid membranes with orange-red fluorescence, supporting membrane visualization, neuronal tracing, and selected cell-based assays. It is insoluble in water, so use an appropriate organic solvent and do not treat it as an aqueous stain or a selective intracellular-organelle marker.
-
Eimeria Infection, Sulfachlorpyridazine, and Cecal Omics
2026-09-23
The reference study integrates 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how Eimeria tenella infection and treatment reshape the chicken cecal environment. Its results distinguish the microbiota-stabilizing pattern associated with ethanamizuril from the reduction of potentially harmful Escherichia-Shigella linked to sulfachlorpyridazine, while showing limited effects from their low-dose combination.
-
Drug Repurposing for DNA Repair in CRISPR
2026-09-22
This study presents a large-scale screen of approved drugs to identify compounds that shift CRISPR-induced double-strand break repair toward NHEJ, MMEJ, or HDR. Its findings connect repair-outcome engineering with synthetic lethality and provide a framework for validating pathway modulators in genome editing, disease modeling, and cancer research.
-
Erastin and Ferroptosis: Assay Logic Beyond Viability
2026-09-22
Erastin is a ferroptosis inducer best used as a mechanistic perturbation rather than a standalone viability reagent. This guide connects redox biology, RAS/BRAF genotype, and necroptosis-aware assay design to improve interpretation in ferroptosis research.
-
SETD7, White Adipose Browning, and Metabolic Health
2026-09-21
The reference study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis and links its depletion to an Adcy7–Sirt1–Creb1 signaling axis. Its mouse and adipocyte experiments suggest that selectively enhancing beige-fat function, rather than simply increasing adipogenesis, may improve energy expenditure and resistance to diet-induced metabolic dysfunction.
-
TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis
2026-09-21
Zhou et al. identify TSPAN18 as a regulator of STIM1 stability: by competing with TRIM32-mediated ubiquitination, TSPAN18 preserves STIM1, enhances store-operated calcium entry, and promotes prostate cancer bone metastasis. The study connects protein degradation control with the calcium signaling pathway and provides a mechanistic framework for evaluating TSPAN18 as a metastasis-related target.
-
Cortistatin, Akt, and Steroid-Induced ONFH
2026-09-20
The reference study identifies reduced cortistatin signaling as a feature of glucocorticoid-associated osteonecrosis of the femoral head and shows that cortistatin protects bone-forming and endothelial cells through GHSR1a/Akt. Its combination of patient samples, a rat model, and dexamethasone-treated cell systems provides a mechanistic framework linking oxidative-stress-related apoptosis, impaired osteogenesis, and vascular dysfunction.
-
Chicken GSDME Drives RNA Virus Pyroptosis
2026-09-19
The reference study identifies chicken GSDME as a principal pore-forming effector of RNA virus-induced pyroptosis, addressing a major gap created by the absence of GSDMD in chickens. Its combination of viral infection, Poly(I:C) stimulation, pathway analysis, and chGSDME loss-of-function experiments defines an MDA5–caspase-8/9–caspase-3/7–GSDME axis with implications for comparative virology and cell-death research.
-
Temafloxacin Activity Against Gram-Negative Bacteria
2026-09-18
Hardy’s overview synthesizes comparative in vitro evidence showing that temafloxacin was highly active against diverse respiratory, enteric, sexually transmitted, and other gram-negative pathogens, while remaining less active than ciprofloxacin against Pseudomonas aeruginosa. Its main contribution is a spectrum-wide interpretation of MIC data alongside pharmacokinetic considerations, helping researchers distinguish broad gram-negative coverage from organism-specific limitations.
-
Shh–Fgf Signaling in Species-Specific Penile Development
2026-09-18
A 2025 Cells study shows that species-specific penile morphogenesis is associated with differential Shh, Fgf10, and Fgfr2 expression in guinea pigs and mice. Combining comparative gene-expression analysis with genital-tubercle culture, the work links reduced Hedgehog and FGF activity to urethral groove formation and provides a framework for interpreting developmental signaling across mammalian models.
-
CGP 55845 hydrochloride for Reliable Assays
2026-09-17
This scenario-based guide explains how CGP 55845 hydrochloride, SKU B5086, can strengthen mechanistic controls in cell-based viability, proliferation, cytotoxicity, and neurotransmission workflows. It covers receptor selectivity, DMSO formulation, assay controls, interpretation against astrocytic GAT-3 biology, and practical vendor-selection criteria.